MyFinsight
Home
Blog
About
Cash and cash
equivalents
$38,412K
(-27.75%↓ Y/Y)
Accounts receivable, net
$29,062K
(21.32%↑ Y/Y)
Inventories
$28,565K
(68.80%↑ Y/Y)
Prepaid expenses and
other current assets
$3,151K
(-40.24%↓ Y/Y)
Total current assets
$99,190K
(-0.13%↓ Y/Y)
Property and equipment,
net
$40,102K
(-2.39%↓ Y/Y)
Right-of-use assets
$24,949K
(0.92%↑ Y/Y)
Goodwill
$7,825K
(-2.87%↓ Y/Y)
Notes receivable
$5,718K
(-5.32%↓ Y/Y)
Other long-term
assets
$3,023K
(-45.53%↓ Y/Y)
Intangible assets, net
$1,650K
(-0.66%↓ Y/Y)
Deferred tax assets
$1,017K
(-18.90%↓ Y/Y)
Total assets
$183,474K
(-2.24%↓ Y/Y)
Total liabilities and
stockholders equity
$183,474K
(-2.24%↓ Y/Y)
Total stockholders
equity
$137,282K
(-7.04%↓ Y/Y)
Lease liabilities
$23,315K
(0.61%↑ Y/Y)
Total current
liabilities
$22,147K
(37.72%↑ Y/Y)
Other long-term
liabilities
$730K
(-3.44%↓ Y/Y)
Accumulated other
comprehensive loss
-$5,329K
(-12.07%↓ Y/Y)
Additional
paid-in-capital
$83,437K
(-6.73%↓ Y/Y)
Retained earnings
$59,040K
(-6.02%↓ Y/Y)
Accrued expenses and
other current...
$15,911K
(40.68%↑ Y/Y)
Accounts payable
$6,236K
(30.71%↑ Y/Y)
Common stock, 0.01 par
value 90,000 shares...
$134K
(-6.94%↓ Y/Y)
Back
Back
Balance Sheet
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)
source: myfinsight.com